Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide 40/5/12.5 mg (TORRENT PHARMACEUTICALS LIMITED)
Welcome to the PulseAid listing for the Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide 40/5/12.5 mg drug offered from TORRENT PHARMACEUTICALS LIMITED. This Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | TORRENT PHARMACEUTICALS LIMITED |
NON-PROPRIETARY NAME: | Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tablet 40/5/12.5 mg |
SUBSTANCE NAME: | OLMESARTAN MEDOXOMIL; AMLODIPINE; HYDROCHLOROTHIAZIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-10-26 |
END MARKETING DATE: | 0000-00-00 |
Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide 40/5/12.5 mg HUMAN PRESCRIPTION DRUG Details:
Item Description | Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide 40/5/12.5 mg from TORRENT PHARMACEUTICALS LIMITED |
LABELER NAME: | TORRENT PHARMACEUTICALS LIMITED |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 40; 5; 12.5(mg/1; mg/1; mg/1) |
START MARKETING DATE: | 2016-10-26 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 13668-386_7b2f628e-b066-47f3-b5da-d6987ef76a29 |
PRODUCT NDC: | 13668-386 |
APPLICATION NUMBER: | ANDA203580 |
Other OLMESARTAN MEDOXOMIL; AMLODIPINE; HYDROCHLOROTHIAZIDE Pharmaceutical Manufacturers / Labelers: